Johnson & Johnson Appoints Senior Leaders to Executive Committee
NEW BRUNSWICK, N.J., Dec. 9, 2021 /PRNewswire/ --Johnson & Johnson (NYSE: JNJ) (the Company) today announced the appointment of several senior leaders to the Company's Executive Committee.
- NEW BRUNSWICK, N.J., Dec. 9, 2021 /PRNewswire/ --Johnson & Johnson (NYSE: JNJ) (the Company) today announced the appointment of several senior leaders to the Company's Executive Committee.
- As previously announced, Mr. Alex Gorsky will serve as Executive Chairman of Johnson & Johnson and transition the Chief Executive Officer role to Mr. Joaquin Duato, currently Vice Chairman of the Company's Executive Committee, effective January 3, 2022.
- Dr. Mathai Mammen, Global Head of R&D at the Janssen Pharmaceutical Companies of Johnson & Johnson, has been appointed Executive Vice President, Pharmaceuticals, R&D.
- Mr. Duato said, "I am thrilled to appoint this group of dynamic and experienced leaders to Johnson & Johnson's Executive Committee.